Minerva Neurosciences, Inc.
NERV· Nasdaq
Released Aug 1, 2023, before the open
10-Q filed Aug 1, 2023, 32 days after period end · 0000950170-23-036159
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $41.18M |
| Net Income | -$6.19M | -$8.72M | -$10.59M | $29.53M |
| EPS Diluted | -$1.12 | -$1.63 |
Minerva Neurosciences, Inc. · CIK 1598646 · Engraved from SEC EDGAR
| -$0.25 |
| $0.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.